Raben David

Raben David is listed in filings as Chief Medical Officer at Bicara Therapeutics Inc. Common Stock. This profile follows SEC Form 4 activity through Apr 28, 2026, including sale activity. Recent filings connect the profile to Bicara Therapeutics Inc. Common Stock (BCAX). The current snapshot covers public activity from Oct 10, 2025 to Apr 28, 2026. Reported amounts are shown as $125.8K to $104.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.